Answers are grounded in this paper and cite their sources.
The US Food and Drug Administration has just approved a new treatment for metastatic pancreatic cancer after a phase 3 trial showed it doubled life expectancy. What do we know about daraxonrasib, asks Katharine Lang, and when will it be available in the UK?
No takes yet. Share an insight, caveat, or question.
Katharine Lang (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: